Replimune Group, Inc. Common Stock (NASDAQ: REPL) last traded at $13.42, up 2.91% on the session. The quote above updates while this page is open; the figures below are drawn from Replimune Group, Inc. Common Stock’s own filings and are restated only when a new one is published.
Replimune Group, Inc. Common Stock trades on NASDAQ under the ticker REPL. Its market capitalisation is $1.26 billion.
Valuation measures for Replimune Group, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.26B |
|---|---|
| Enterprise value | $1.23B |
| Price / book | 11.97 |
| Beta | 1.51 |
Trailing-twelve-month figures tagged in Replimune Group, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$297.01M |
| EPS (TTM) | -$3.15 |
|---|
| Return on equity | -281.14% |
|---|
| Cash | $185.36M |
|---|
Range and volume for REPL over the past 52 weeks.
| 52-week high | $16.33 |
|---|---|
| 52-week low | $1.50 |
| Volume | 2.02M |
| Average volume | 4.19M |
| Previous close | $13.04 |
Invest a chosen dollar amount in Replimune Group, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell REPL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.